141 related articles for article (PubMed ID: 35134470)
1. Meta-analysis of microRNA profiling data does not reveal a consensus signature for B cell acute lymphoblastic leukemia.
Longjohn MN; Squires WRB; Christian SL
Gene; 2022 May; 821():146211. PubMed ID: 35134470
[TBL] [Abstract][Full Text] [Related]
2. [Bioinformatics analysis of microRNA comprehensive regulatory network in B- cell acute lymphoblastic leukemia].
Zeng MN; Ma WL; Zheng WL
Zhonghua Xue Ye Xue Za Zhi; 2016 Jul; 37(7):585-90. PubMed ID: 27535859
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Valiollahi E; Ribera JM; Genescà E; Behravan J
Mol Biol Rep; 2019 Feb; 46(1):1295-1306. PubMed ID: 30712246
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J
Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180
[TBL] [Abstract][Full Text] [Related]
6. Six Candidate miRNAs Associated With Early Relapse in Pediatric B-Cell Acute Lymphoblastic Leukemia.
Amankwah EK; Devidas M; Teachey DT; Rabin KR; Brown PA
Anticancer Res; 2020 Jun; 40(6):3147-3153. PubMed ID: 32487609
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia.
Mi S; Lu J; Sun M; Li Z; Zhang H; Neilly MB; Wang Y; Qian Z; Jin J; Zhang Y; Bohlander SK; Le Beau MM; Larson RA; Golub TR; Rowley JD; Chen J
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19971-6. PubMed ID: 18056805
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Molecular Mechanisms of Pterygium by Constructing lncRNA-miRNA-mRNA Regulatory Network.
Xu N; Cui Y; Dong J; Huang L
Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):12. PubMed ID: 32645133
[TBL] [Abstract][Full Text] [Related]
10. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia.
Ju X; Li D; Shi Q; Hou H; Sun N; Shen B
Pediatr Hematol Oncol; 2009 Jan; 26(1):1-10. PubMed ID: 19206004
[TBL] [Abstract][Full Text] [Related]
11. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia.
Zanette DL; Rivadavia F; Molfetta GA; Barbuzano FG; Proto-Siqueira R; Silva WA; Falcão RP; Zago MA
Braz J Med Biol Res; 2007 Nov; 40(11):1435-40. PubMed ID: 17934639
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia.
Duyu M; Durmaz B; Gunduz C; Vergin C; Yilmaz Karapinar D; Aksoylar S; Kavakli K; Cetingul N; Irken G; Yaman Y; Ozkinay F; Cogulu O
Biomed Res Int; 2014; 2014():967585. PubMed ID: 24955371
[TBL] [Abstract][Full Text] [Related]
14. miR-324-3p and miR-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia.
Zamani A; Fattahi Dolatabadi N; Houshmand M; Nabavizadeh N
Leuk Res; 2021 Oct; 109():106643. PubMed ID: 34147937
[TBL] [Abstract][Full Text] [Related]
15. [The expression and regulatory mechanism of microRNA-708 in pediatric common B-cell acute lymphoblastic leukemia].
Li X; Li D; Zhuang Y; Shi Q; Wei W; Zhang H; Ju XL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):138-43. PubMed ID: 23611221
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations.
Rashed WM; Hammad AM; Saad AM; Shohdy KS
Crit Rev Oncol Hematol; 2019 Apr; 136():70-78. PubMed ID: 30878131
[TBL] [Abstract][Full Text] [Related]
17. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia.
Schotte D; Chau JC; Sylvester G; Liu G; Chen C; van der Velden VH; Broekhuis MJ; Peters TC; Pieters R; den Boer ML
Leukemia; 2009 Feb; 23(2):313-22. PubMed ID: 18923441
[TBL] [Abstract][Full Text] [Related]
18. miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia.
El-Khazragy N; Noshi MA; Abdel-Malak C; Zahran RF; Swellam M
J Cell Biochem; 2019 Apr; 120(4):6315-6321. PubMed ID: 30362157
[TBL] [Abstract][Full Text] [Related]
19. Expression of microRNA-181a and microRNA-196b in Egyptian Pediatric acute Lymphoblastic Leukemia.
Shafik RE; Abd El Wahab N; Mokhtar MM; El Taweel MA; Ebeid E
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3429-3434. PubMed ID: 33247705
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.
Schotte D; De Menezes RX; Akbari Moqadam F; Khankahdani LM; Lange-Turenhout E; Chen C; Pieters R; Den Boer ML
Haematologica; 2011 May; 96(5):703-11. PubMed ID: 21242186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
